40
Participants
Start Date
August 31, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Omega-3 (EPA+DHA)
In this study omega-3 will be the real thing mega omega supreme capsule, it will be used as an adjunct therapy with TB treatment in the intensive phase of treatment. Participant will receive x3, 1g capsules which will provide approximately 2g of EPA and DHA
Placebo
This group will receive the placebo, which will be 3 x 1g capsules of high linoleic sunflower oil, the sunflower capsules have been encapsulated to match the dimension of the omega 3 supplement. The capsules will also be given as and adjunct to TB treatment of the intensive phase of TB treatment
Perinatal HIV research Unit (Matlosana), Klerksdorp
Perinatal HIV Research Unit of the University of the Witswatersrand
OTHER
North-West University, South Africa
OTHER